High prevalence of triple-negative tumors in an urban cancer center.
about
The epidemiology of triple-negative breast cancer, including raceAfrican ancestry and higher prevalence of triple-negative breast cancer: findings from an international studyPatterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors.Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011).Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patientsDistinct breast cancer subtypes in women with early-onset disease across racesTwist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancerManagement options in triple-negative breast cancerEthnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white womenGenome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women.Triple-Negative Breast Cancer: Clinical and Histological Correlations.Early developments in gene-expression profiling of breast tumors: potential for increasing black-white patient disparities in breast cancer outcomes?Outcome for patients with triple-negative breast cancer is not dependent on race/ethnicity.Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations.Triple-negative breast cancer and obesity in a rural Appalachian population.A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survivalPatient navigation: an update on the state of the science.The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancerPopulation and target considerations for triple-negative breast cancer clinical trials.Impact of body mass index on prognostically relevant breast cancer tumor characteristics.Study of hormone receptors and epidermal growth factor expression in invasive breast cancers in a cohort of Western India.Triple-negative breast cancers are increased in black women regardless of age or body mass indexIRAK4 and TLR3 Sequence Variants may Alter Breast Cancer Risk among African-American WomenPrevalence of cancer visits by physician specialty, 1997-2006Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors.Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort studyBRCA sequencing and large rearrangement testing in young Black women with breast cancer.Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.The paradox of triple negative breast cancer: novel approaches to treatment.Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women.Triple negative and basal-like breast cancer in East Africa.Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.Breast cancer survival in women of African descent living in the US and in the Caribbean: effect of place of birth.Heterogeneity of breast cancer clinical characteristics and outcome in US black women--effect of place of birth.microRNA-10b expression and its correlation with molecular subtypes of early invasive ductal carcinoma.Secreted CLU is associated with the initiation of triple-negative breast cancer.Evaluation of Breast Cancer (BC) Awareness among Female University Students in Zarqa University, Jordan
P2860
Q24289471-E4C7784F-F208-4087-B94D-B053998347BBQ24632274-C83F8465-A950-45C7-A7F4-F73A0579289EQ30301315-DAC5A424-7840-4D96-A550-57214FF4A4CAQ30813968-5D51BDAA-5DA9-4411-BF94-964C0FD3C685Q33842913-88A2EF81-2BFC-43F3-8686-DFB371765DA5Q33932660-B7E57A0F-F870-4F7B-80D9-1DAE428E8684Q34207659-DA94DD32-3008-437D-8FF0-3925CC5558D7Q35155460-DE9BC1D0-246F-4B76-9B76-E60FB0862622Q35267097-D5247886-0B24-458F-BC76-901A1983A5AAQ35573190-30593BBC-749A-4E9D-900E-C40EB9FCF9CAQ35576252-341EF1A8-CAB0-41D7-8ECF-7ECF83E56998Q35622059-572F4A81-2259-4FED-B3D9-C32C2246B3E4Q35974918-0307B6D0-CBA6-449A-B8B8-20EEC1DD5E57Q36288288-B0BBE7E3-D402-44CA-85E2-DF1B834D8598Q36333924-6E09BA7E-B41F-4DC7-8C18-FE3EEACAC940Q36338690-5A04D18F-AE0C-4882-B754-61A824096DDBQ36542202-FB98C4BE-4F49-42BB-AC39-8611DE72BD6FQ36554668-060E0760-5FCE-4365-B0BC-12D1B50C36B1Q36757512-D63E07AE-D5E7-4748-B3E1-81C841567CA0Q36884986-434ECF47-0B3F-4344-A326-9FA340539C25Q36914317-9E81EA31-7CE4-4B8F-9750-FA6F745FF336Q37058003-01AD9929-4C30-42E2-8C1B-2A4F8A8CF67DQ37199409-5785C8C9-5034-4DAE-B400-6AFB2A31E895Q37208769-22C638B8-91B1-42A5-A0A5-7942D101E8D0Q37261748-293DFC45-D07A-45CE-9D06-BA96D54C13A7Q37265072-3F3DA101-9AE5-41A0-A2E4-94B4FD73E49BQ37277141-A0BD6174-C829-4B8F-8D08-4E9F8E2E7E7DQ37305988-9391DBF3-461B-487F-B9C1-4054C24DBDDBQ37639406-65BFF1DA-8F77-4B2A-BC72-EABA750A4BB0Q37687380-FE5B2F06-AAA4-4456-B8EF-C2FD27C08B69Q37958063-FFECD750-AF3C-4070-9238-E3295B64115BQ42443819-CE7F0122-0412-409C-A9B1-1F5F4225480BQ42491445-B0F7C8F6-CCCE-488A-8637-A243EC88D063Q44463727-1EB8EBFE-FEFC-4476-A963-16F46D2359B1Q45028435-BCB77B3F-5745-4B65-8FDA-BC697A356638Q46251244-8DD2C225-02AA-4B48-8847-C4D443E5BD61Q52620485-91936310-B0ED-4BA0-8BD4-856A8CE53A0CQ54325444-025CC86A-9867-48B7-967C-828C8DAED94BQ57054857-F44CEFE3-CE2F-4A7D-AE66-C38725A4D3C3
P2860
High prevalence of triple-negative tumors in an urban cancer center.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
High prevalence of triple-negative tumors in an urban cancer center.
@en
High prevalence of triple-negative tumors in an urban cancer center.
@nl
type
label
High prevalence of triple-negative tumors in an urban cancer center.
@en
High prevalence of triple-negative tumors in an urban cancer center.
@nl
prefLabel
High prevalence of triple-negative tumors in an urban cancer center.
@en
High prevalence of triple-negative tumors in an urban cancer center.
@nl
P2093
P356
P1433
P1476
High prevalence of triple-negative tumors in an urban cancer center.
@en
P2093
Ebonee N Butler
Gabriela M Oprea-Ilies
Harvey L Bumpers
Joel Okoli
Mary Jo B Lund
Monica Rizzo
Nadjo Hatchett
Otis W Brawley
Sheryl G A Gabram
Victoria L Green
P304
P356
10.1002/CNCR.23569
P407
P577
2008-08-01T00:00:00Z